2024. A CASE OF MONOCLONAL ANTIBODY (RITUXIMAB) INDUCED POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME (PRES) IN A PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS. Romanian Journal of Diabetes, Nutrition and Metabolic Diseases. 31, 1 (Apr. 2024), 698–704.